Legal Representation
Attorney
Ryan Wertman
USPTO Deadlines
Next Deadline
1106 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20221227)
Due Date
December 27, 2028
Grace Period Ends
June 27, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 27, 2022 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Dec 27, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Oct 11, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 11, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 21, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 8, 2022 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 15, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Aug 15, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Aug 15, 2022 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Aug 15, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Aug 1, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 31, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 31, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 22, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Apr 22, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Apr 22, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Apr 20, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 24, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 29, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Genetic research; genetic engineering services; scientific research in the field of genetics and genetic engineering; scientific research in the field of biotechnology; biotechnology testing, namely, the use AI-powered whole genome sequencing for scientific and medical research use to analyze tumor biology; research and development in the field of biotechnology; design and writing of computer programs for biotechnological applications for others; research and development in the pharmaceutical and biotechnology fields; providing scientific research information in the field of biochemistry and biotechnology; Providing information about medical and scientific research in the fields of cancer, vaccines and medical diagnostic instruments
First Use Anywhere:
Jul 10, 2021
First Use in Commerce:
Jul 10, 2021
Class 044
Biotechnology testing, namely, the use of AI-powered whole genome sequencing for medical diagnostic and treatment purposes to analyze tumor biology; genetic testing for medical diagnostic and treatment purposes; genetic testing for medical diagnostic and treatment purposes to determine the appropriate medical antineoplastic therapy
First Use Anywhere:
Jul 10, 2021
First Use in Commerce:
Jul 10, 2021
Classification
International Classes
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOSCIENCE"